Image

Modulating Energy Density in Time-Restricted Eating

Recruiting
50 - 75 years of age
Both
Phase N/A

Powered by AI

Overview

The goal of this randomized controlled trial is to test the effect of time-restricted eating (14-hour fast, 10-hour eating window) of a low-energy dense diet (reduced calories per gram of food) in older adults with obesity and insulin resistance. The study aims to determine if modulating the energy density of the diet reduces:

  1. Insulin resistance and
  2. Body weight.

Researchers will compare the groups:

  1. Following time-restricted eating and given a diet reduced in energy density or
  2. Following time-restricted eating and given a diet typically consumed in this population

Description

The study is an eight-week randomized controlled double-blinded clinical trial. Participants will follow time-restricted eating (14-hour fast, 10-hour eating window), and will be randomized to a diet low in energy density or the usual diet. Meals will be prepared in a metabolic kitchen and dispensed to participants. Dietitians will monitor dietary compliance. A blood sample will be drawn and body weight will be measured before starting the intervention and after completing it.

Eligibility

Inclusion Criteria:

  1. Body mass index (BMI) ≥ 30kg/m2.
  2. Mini-Mental State Examination (MMSE) > 25
  3. Geriatric Depression Scale-15 (GDS-15) < 9
  4. Homeostatic model assessment of insulin resistance (HOMA-IR) ≥ 3.

Exclusion Criteria:

  1. Diagnosis of Type 2 diabetes received more than five years ago
  2. Diagnosis of type 1 diabetes
  3. Evidence of clinically significant renal dysfunction or disease
  4. History of malignancy during the past five years
  5. Being treated with systemic steroids, olanzapine, or clozapine
  6. Being treated with prescription medications for obesity
  7. Being treated with thiazolidinediones, glucagon-like-receptor agonists, Dipeptidyl Peptidase IV inhibitors, and insulin
  8. Weight change > 3 kg in the preceding three months
  9. Any disease or condition that precludes testing of the study outcomes or makes it unsafe to consume the foods being tested in the study, or subjects are otherwise deemed to be unsuitable for participation in the study (determined by the investigative team)

Study details

Insulin Resistance, Body Weight

NCT06259435

Pennington Biomedical Research Center

8 June 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.